Viewing Study NCT02540161


Ignite Creation Date: 2025-12-24 @ 12:48 PM
Ignite Modification Date: 2026-01-27 @ 10:10 PM
Study NCT ID: NCT02540161
Status: COMPLETED
Last Update Posted: 2020-08-05
First Post: 2015-09-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma
Sponsor: Annick Desjardins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sym004 View
None Glioblastoma View
None Desjardins View
None Pro00063483 View
None Symphogen View
None Duke Cancer Institute View